|Day Low/High||5.15 / 5.29|
|52 Wk Low/High||4.58 / 12.53|
Revenue is where it's at for cannabis in 2019.
A huge week is coming up for these well-known stocks.
Overwhelmed by the cannabis earnings reports? Here's the metric that Jim Cramer watches.
Tilray shares turn following the company's fourth-quarter results while other pot stocks trade mixed.
Short interest is back in the low single digits while Tilray still enjoys one of the smallest floats for a cannabis company.
Tilray's wide trading range on Tuesday is relatively calm considering the important levels it's teetering on.
Apparently, this game is all about growth right now. It certainly is not about margins.
Last week was a very good one for the portfolio as nine of our 13 holdings outperformed our benchmark, the Russell 2000.
Tilray is expected to increase its revenue by more than 50% from the previous quarter.
Some momentum movers are becoming extended and have seen profit-taking Monday.
Assessing Aurora and its peers, strictly on the numbers.
In this day and age, companies must be 'disruptors' or get left in the dust.
Stocks ended higher Wednesday as Wall Street looks past uncertainty about Brexit and worries about Boeing after the United States became the latest country to ground the 737 Max 8.
Peltz's addition should pacify a persistent critique of the company.
When you're done gawking at the S&P, Aurora Cannabis rose 12% Wednesday, but may have even more juice left in it short-term
Aurora Cannabis' hiring of deal maker Nelson Peltz opens up a wealth of new possibilities for the Canadian pot company.
I know that Nelson is fascinated by the medicinal properties chiefly as a replacement for opioids, the scourge of this country.
Aurora Cannabis shares were indicated sharply higher Wednesday after it named billionaire activist investor Nelson Peltz as a strategic adviser to the Canada-based group.
Aurora's prominent partner could be cannabis' key to breaking into consumer segments.
The plan is for Peltz to help the firm in maximizing potential markets to target.
Nelson Peltz may be making Aurora relevant in today's headlines, but it's who invests money in the companies that counts, according to Jim Cramer.
Jim Cramer's got some thoughts on cannabis and whether or not it's time to break up big tech.
We will trim part of our Pareteum holdings as the stock has surpassed our price target.
Themes like cannabis tend to persist longer than many think they will.
The price of ACB is moving up today and a fresh look at the charts and indicators seems like a good idea.
Wondering what's moving these markets? Here's what Jim Cramer thinks about Aurora Cannabis adding Nelson Peltz as an advisor and the proposals to break up big tech.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.